These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17497610)

  • 61. Limited microsurgical arteriolysis for complications of digital vasospasm.
    Tham S; Grossman JA
    J Hand Surg Br; 1997 Jun; 22(3):359-61. PubMed ID: 9222917
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PROGNOSIS IN RAYNAUD'S PHENOMENON AFTER SYMPATHECTOMY.
    JOHNSTON EN; SUMMERLY R; BIRNSTINGL M
    Br Med J; 1965 Apr; 1(5440):962-4. PubMed ID: 14260626
    [No Abstract]   [Full Text] [Related]  

  • 64. The diagnosis and treatment of Raynaud's phenomenon: a practical approach.
    Pope JE
    Drugs; 2007; 67(4):517-25. PubMed ID: 17352512
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Behavioral treatment of Raynaud's phenomenon in scleroderma.
    Freedman RR; Ianni P; Wenig P
    J Behav Med; 1984 Dec; 7(4):343-53. PubMed ID: 6520866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prolonged improvement of Raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapy.
    Fritzler MJ; Hart DA
    Arthritis Rheum; 1990 Feb; 33(2):274-6. PubMed ID: 2106327
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Raynaud's phenomenon.
    Haque A; Hughes M
    Clin Med (Lond); 2020 Nov; 20(6):580-587. PubMed ID: 33199324
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma.
    Cappelli L; Wigley FM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):419-38. PubMed ID: 26210127
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma).
    Velayos EE; Masi AT; Stevens MB; Shulman LE
    Arch Intern Med; 1979 Nov; 139(11):1240-4. PubMed ID: 508020
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcomes of periarterial sympathectomy in patients with digital ischemia.
    Elshabrawy AA; Elkassaby M; Abdelgawad MS; Atif E; Megahed A; Regal S
    Vascular; 2022 Oct; 30(5):859-866. PubMed ID: 34256627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Articular Surgery of the Ischemic Hand in Systemic Scleroderma: A Vascular Basis for Arthrodesis and Arthroplasty.
    Melone CP; Dayan E
    J Hand Surg Am; 2018 Jun; 43(6):574.e1-574.e9. PubMed ID: 29650377
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Current indications for superior dorsal sympathectomy. Apropos of 84 cases].
    Touati Y; Mathieu JP; Houel F; Imbert P
    J Mal Vasc; 1982; 7(3):187-92. PubMed ID: 7142820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [To what degree does cervicothoracic gangliectomy associated with dorsal radicotomy guarantee a thorough sympathectomy of the upper extremity; in connection with the treatment of scleroderma, associated with a severe case of Raynaud's disease].
    MENTHA C
    Schweiz Med Wochenschr; 1956 May; 86(Suppl 20):583-4. PubMed ID: 13337258
    [No Abstract]   [Full Text] [Related]  

  • 76. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Periarterial sympathectomy of the radial and ulnar arteries in Raynaud's phenomenon--a preliminary study].
    Balogh B; Mayer W; Vesely M; Partsch H; Piza-Katzer H
    Handchir Mikrochir Plast Chir; 2002 Nov; 34(6):374-80. PubMed ID: 12601603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low molecular weight dextran infusions in systemic sclerosis with Raynaud's phenomenon: a report of nine cases.
    Lane P
    Br Med J; 1970 Dec; 4(5736):657-9. PubMed ID: 5488384
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Raynaud's disease.
    Birnstingl M
    Proc R Soc Med; 1968 Aug; 61(8):790-2. PubMed ID: 5673408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.